RxDoctor Payments Data

Melanie Black

Family · Borger, TXNPI 1013558675

Payments from drug & device makers

$563in general payments, 2019–2025

Across 31 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$188
  • AstraZeneca$74
  • Lilly USA, LLC$42
  • GSK$31
  • Biohaven Pharmaceutical Holding Company Ltd.$29
  • Pfizer$27
  • plus $171 from 10 others

What the payments were for

  • Food & beverage$563100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$563 in reported general payments places this provider in the 55th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$67,032
Medicare patients
222
Services billed
1,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$61,280
EliquisApixaban38$45,468
MounjaroTirzepatide22$22,519
Tresiba Flextouch U-200Insulin Degludec12$21,869
FarxigaDapagliflozin Propanediol19$21,469
JardianceEmpagliflozin17$21,142
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,000
Tresiba Flextouch U-100Insulin Degludec15$10,101
Ventolin HfaAlbuterol Sulfate29$2,039
Gabapentin79$1,718
Levothyroxine Sodium182$1,530
Albuterol Sulfate HfaAlbuterol Sulfate44$1,341
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,232
Losartan Potassium107$1,163
Metformin Hcl115$984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$61,28065 claims
PfizerEliquis$27$45,46838 claims
Lilly USA, LLCMounjaro$42$22,51922 claims
AstraZenecaFarxiga$74$21,46919 claims
Boehringer IngelheimJardiance$16$21,14217 claims
GSKTrelegy Ellipta$31$20,00030 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 15,456 family providers in Texas.

Other family in Borger

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →